Study details
Enrolling now
Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section
Senthil Sadhasivam
NCT IDNCT05380531ClinicalTrials.gov data as of Apr 2026
Target enrollment
600
Study length
about 3.9 years
Ages
18+
Sex
Female only
Locations
4 sites in IN, MO, PA
About this study
This trial is testing a new way to manage pain after a C-section. It involves genetic testing before surgery to personalize the treatment approach. The goal is to reduce opioid use and improve outcomes for mothers and babies.
Based on ClinicalTrials.gov records.
What participants do
- 1.Preoperative Genotyping
Primary goalLook at genetic factors predisposing patients to inadequate surgical pain relief with oxycodone
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low8%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Look at genetic factors predisposing patients to inadequate surgical pain relief with oxycodone
Body systems
Psychiatry / Mental Health